GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study.
Continuation of GnRH analogue after ovum retrieval produces a faster decline in vascular endothelial growth factor levels and ascitis in women at risk of ovarian hyperstimulation syndrome.